Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001426899 | SCV001629560 | likely benign | Pancreatic adenocarcinoma | 2023-09-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004038242 | SCV002607370 | likely benign | not specified | 2022-04-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003438790 | SCV004151811 | likely benign | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | PALLD: BP4, BP7 |